BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30142729)

  • 21. Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteers.
    Dorr RT; Ertl G; Levine N; Brooks C; Bangert JL; Powell MB; Humphrey S; Alberts DS
    Arch Dermatol; 2004 Jul; 140(7):827-35. PubMed ID: 15262693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic delivery of melanotan II through the ocular route in rabbits.
    Pinsuwan S; Myrdal PB; Yalkowsky SH
    J Pharm Sci; 1997 Mar; 86(3):396-7. PubMed ID: 9050812
    [No Abstract]   [Full Text] [Related]  

  • 23. Melanotan-associated melanoma.
    Paurobally D; Jason F; Dezfoulian B; Nikkels AF
    Br J Dermatol; 2011 Jun; 164(6):1403-5. PubMed ID: 21564053
    [No Abstract]   [Full Text] [Related]  

  • 24. Melanotan-induced priapism: a hard-earned tan.
    Dreyer BA; Amer T; Fraser M
    BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30796078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eruptive melanocytic naevi following melanotan injection.
    Cousen P; Colver G; Helbling I
    Br J Dermatol; 2009 Sep; 161(3):707-8. PubMed ID: 19575725
    [No Abstract]   [Full Text] [Related]  

  • 26. Preformulation studies with melanotan-II: a potential skin cancer chemopreventive peptide.
    Lan EL; Ugwu SO; Blanchard J; Fang X; Hruby VJ; Sharma S
    J Pharm Sci; 1994 Aug; 83(8):1081-4. PubMed ID: 7983590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. alpha-Melanocyte-stimulating hormone-induced eruptive nevi.
    Cardones AR; Grichnik JM
    Arch Dermatol; 2009 Apr; 145(4):441-4. PubMed ID: 19380666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin pigmentation and pharmacokinetics of melanotan-I in humans.
    Ugwu SO; Blanchard J; Dorr RT; Levine N; Brooks C; Hadley ME; Aickin M; Hruby VJ
    Biopharm Drug Dispos; 1997 Apr; 18(3):259-69. PubMed ID: 9113347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanotan-associated melanoma in situ.
    Ong S; Bowling J
    Australas J Dermatol; 2012 Nov; 53(4):301-2. PubMed ID: 22724573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zebrafish Bioassay for Screening Therapeutic Candidates Based on Melanotrophic Activity.
    Hong TI; Hwang KS; Choi TI; Kleinau G; Scheerer P; Bang JK; Jung SH; Kim CH
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consider underlying body dysmorphic disorder in users of melanotan.
    Affleck A
    Br J Dermatol; 2010 Feb; 162(2):459-60. PubMed ID: 19919633
    [No Abstract]   [Full Text] [Related]  

  • 32. Having it all.
    Gura T
    Science; 2003 Feb; 299(5608):850. PubMed ID: 12574617
    [No Abstract]   [Full Text] [Related]  

  • 33. Determination of melanotan-II in rat plasma by liquid chromatography/tandem mass spectrometry: determination of pharmacokinetic parameters in rat following intravenous administration.
    Mock S; Shen X; Tamvakopoulos C
    Rapid Commun Mass Spectrom; 2002; 16(22):2142-7. PubMed ID: 12415547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The risks of tanning with the Barbie drug].
    Eijmael MJPM; Janmaat CJ; Briët-Schipper EMN
    Ned Tijdschr Geneeskd; 2022 May; 166():. PubMed ID: 35736369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudoleucoderma after injections of afamelanotide in a patient with atopic dermatitis.
    von Bartenwerffer W; Siebenhaar G; Hunzelmann N
    Acta Derm Venereol; 2011 Sep; 91(5):578-9. PubMed ID: 21597671
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemodynamic actions and mechanisms of systemically administered α-MSH analogs in mice.
    Rinne P; Tikka S; Mäkelä S; Streng T; Savontaus E
    Peptides; 2012 Nov; 38(1):150-8. PubMed ID: 22982611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of conformational isomerism in alpha-melanocyte stimulating hormone by design of cyclic analogues.
    Nikiforovich GV; Sharma SD; Hadley ME; Hruby VJ
    Biopolymers; 1998 Sep; 46(3):155-67. PubMed ID: 9699465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle4-D-Phe7]-alpha-MSH in humans.
    Dorr RT; Dvorakova K; Brooks C; Lines R; Levine N; Schram K; Miketova P; Hruby V; Alberts DS
    Photochem Photobiol; 2000 Oct; 72(4):526-32. PubMed ID: 11045725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change in moles linked to use of unlicensed "sun tan jab".
    Langan EA; Ramlogan D; Jamieson LA; Rhodes LE
    BMJ; 2009 Jan; 338():b277. PubMed ID: 19174439
    [No Abstract]   [Full Text] [Related]  

  • 40. [Local pigment stimulation by alpha-melanocyte stimulating hormone in the human: intracutaneous injections without and with ultraviolet irradiation].
    Remy W; Rakoski J; von Mayenburg J
    Z Hautkr; 1989 Jun; 64(6):459-60. PubMed ID: 2548353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.